1st Quarter - Report

RED+BLUE STRATEGIES for PEW CHARITABLE TRUSTS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation and rulemaking related to the Physician Payment Sunshine Act- a Medicare-related provision in the health reform law focused on systemic transparency.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE

Health Issues HCR

H.R. 2182/S.1734 - The Generating Antibiotic Incentives Now Act. Supporting work to increase innovation in the development of new antibiotics. S. 1584 - The Drug Safety and Accountability Act. Supporting upstream supply chain safety issues. S. 3026 - Safeguarding America's Pharmaceuticals Act Supporting downstream supply chain issues. Implementation and rulemaking related to the Physician Payment Sunshine Act - A Medicare-related provision in the Health Reform Law focused on increasing systemic transparency. Improvement of safety and efficacy of medical devices. Work related to treatment of medical devices in the upcoming FDA user fee arena.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 1584 (112th), S. 1734 (112th), H.R. 2182 (112th), S. 3026 (112th)

Pharmacy PHA

H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act . Supporting work to increase innovation and development of new antibiotics. S. 1584 - Drug Safety and Accountability Act- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety. Policies related to the growing concerns regarding drug shortage issues in hospitals across the country. Related issues being considered in pending User Fee Reauthorization legislation.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1734 (112th), H.R. 3026 (112th), H.R. 2182 (112th), S. 1584 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.